New drug aims to save limbs from amputation
NCT ID NCT07352800
Summary
This study is testing a new injectable medicine called APAC, which is designed to prevent dangerous blood clots. It aims to see if APAC is safe and to find the best dose for people with severely blocked arteries in their legs, a condition that can lead to amputation. The study will involve 42 patients, some of whom will receive APAC alongside a standard procedure to open their arteries, and will track their health for up to six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Helsinki University Hospital
RECRUITINGHelsinki, 00290, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tampere University Hospital
NOT_YET_RECRUITINGTampere, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Turku University Hospital
NOT_YET_RECRUITINGTurku, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.